Assessment of the general condition and quality of life of women of post-reproductive age after asymptomatic COVID-19 and 12 months after moderate COVID-19

   The aim. To assess the general condition, laboratory parameters, quality of life of women of post-reproductive age after asymptomatic COVID-19 and 12 months after moderate COVID-19.
   Material and methods. We examined 47 women (45–69 years old), divided into 3 groups: those who did not have COVID-19, not vaccinated (group 1 – control; n = 15); women 12 months after moderate COVID-19, accompanied by pneumonia (group 2; n = 19); women with IgG in their blood who deny any symptoms of COVID-19 (group 3; n = 13).
   Results and discussion. An assessment of the general condition of women in post-reproductive age was carried out. In women 12 months after COVID-19 we found a lower level of total bilirubin compared to the group with asymptomatic COVID-19 (p = 0.004). An increase in thrombin time was determined in the groups of patients with symptomatic (p = 0.014) and asymptomatic (p = 0.025) COVID-19 course compared with the control group. Patients with asymptomatic COVID-19 course had a higher level of high-density lipoprotein cholesterol compared with the control group (p = 0.016) and the group 2 (p = 0.006). Compared with the control group, the group 2 had lower scores for general health (p = 0.006), vital activity (p = 0.013), general physical well-being (p = 0.039), physical functioning (p = 0.046); and the group 3 had higher scores in role functioning due to physical condition (p = 0.049). When comparing groups 2 and 3, lower scores in the group of women who recovered from the moderate COVID-19 were found in physical functioning (p = 0.002), pain intensity (p = 0.034), role functioning due to physical condition (p = 0.049), general health (p = 0.003), vital activity (p = 0.018), general physical well-being (p = 0.001).
   Conclusion. 12 months after moderate COVID-19, there is a pronounced deterioration in physical and emotional health; and in asymptomatic patients, better protective functions of an organism can be assumed.

1. Weiss P., Murdoch D. R. Clinical course and mortality risk of severe COVID-19. Lancet. 2020; 395 (10229): 1014-1015. doi: 10.1016/S0140-6736(20)30633-4

2. Puelles V. G., Lütgehetmann M., Lindenmeyer M. T., Sperhake J. P., Wong M. N., Allweiss L., et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020; 383 (6): 590-592. doi: 10.1056/NEJMc2011400

3. Zhang J., Wang X., Jia X., Li J., Hu K., Chen G., et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26 (6): 767-772. doi: 10.1016/j.cmi.2020.04.012

4. Nekaeva E. S., Bolshakova A. E., Malysheva E. S., Galova E. A., Makarova E. V., Nekrasova T. A., et al. Gender characteristics of the novel coronavirus infection (COVID-19) in middle-aged adults. Sovremennye tehnologii v medicine. 2021; 13 (4): 16-26, doi: 10.17691/stm2021.13.4.02

5. Prinelli F., Trevisan C., Noale M., Franchini M., Giacomelli A., Cori L., et al. Sex- and gender-related differences linked to SARS-CoV-2 infection among the participants in the web-based EPI-COVID19 survey: the hormonal hypothesis. Maturitas. 2022; 158: 61-69. doi: 10.1016/j.maturitas.2021.11.015

6. National Institute for Health and Care Excellence. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. London, UK; 2020. URL:https://www.nice.org.uk/guidance/ng188 [date of access: 25. 03. 2022].

7. Amirov N. B., Davletshina E. I., Vasilieva A. G., Fatykhov R. G. Post-COVID syndrome: Multisystem “deficits”. Vestnik sovremennoi klinicheskoi mediciny. 2021; 14 (6): 94-104. (In Russ.). URL: https://cyberleninka.ru/article/n/postkovidnyy-sindrom-multisistemnye-defitsity?ysclid=lbdalakxn6757397914

8. Raman B., Cassar M. P., Tunnicliffe E. M., Filippini N., Griffanti L., Alfaro-Almagro F., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021; 31: 100683. doi: 10.1016/j.eclinm.2020.100683.

9. Bryukhina E. V., Usoltseva E. N., Ivanova O. V. The quality of life in women according to climacteric syndrome. Obstetrics and Gynecology. 2014; 10: 52-58. (In Russ.).

10. Kolesnikova L. I., Kolesnikov S. I., Madaeva I. M., Semenova N. V. Ethnogenetic and molecular-metabolic aspects of sleep disorders in menopause. Moscow, 2019. (In Russ.).

11. Ware J. E. Jr., Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. 1992; 30: 473-483.

12. Piepoli M. F., Hoes A. W., Agewall S., Albus C., Brotons C., Catapano A. L., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular disease Prevention in Clinical Practice. Eur Heart J. 2016; 37 (29): 2315-2381. doi: 10.1093/eurheartj/ehw106

13. Kamyshnikov V. S. Handbook of clinical biochemical research and laboratory diagnostics. Moscow: MEDpress-inform; 2009. (In Russ.).

14. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5

15. Guan W. J., Ni Z. Y., Hu Y., Liang W. H., Ou C. Q., He J. X., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382 (18): 1708-1720. doi: 10.1056/NEJMoa2002032

16. Ziberna L., Martelanc M., Franko M., Passamonti S. Bilirubin is an endogenous antioxidant in human vascular endothelial cells. Sci Rep. 2016; 6: 29240. doi: 10.1038/srep29240

17. Maruhashi T., Kihara Y., Higashi Y. Bilirubin and endothelial function. J Atheroscler Thromb. 2019; 26 (8): 688-696. doi: 10.5551/jat.RV17035

18. Gadotti A. C., Lipinski A. L., Vasconcellos F. T., Marqueze L. F., Cunha E. B., Campos A. C., et al. Susceptibility of the patients infected with SARS-CoV-2 to oxidative stress and possible interplay with severity of the disease. Free Radic Biol Med. 2021; 165: 184-190. doi: 10.1016/j.freeradbiomed.2021.01.044

19. Martín-Fernández M., Aller R., Heredia-Rodríguez M., Gómez-Sánchez E., Martínez-Paz P., Gonzalo-Benito H., et al. Lipid peroxidation as a hallmark of severity in COVID-19 patients. Redox Biol. 2021; 6 (48): 102181. doi: 10.1016/j.redox.2021.102181

20. Rychkova L. V., Darenskaya M. A., Semenova N. V., Kolesnikov S. I., Petrova A. G., Nikitina O. A., et al. Oxidative stress intensity in children and adolescents with a new coronavirus infection. International Journal of Biomedicine. 2022; 12 (2): 242-246. doi: 10.21103/Article12(2)_OA7

21. Semenova N. V., Rychkova L. V., Darenskaya M. A., Kolesnikov S. I., Nikitina O. A., Petrova A. G., et al. Superoxide dismutase activity in male and female patients of different age with moderate COVID-19. Bull Exp Biol Med. 2022; 173 (1): 51-53. doi: 10.1007/s10517-022-05491-6

22. Kudinov V. A., Alekseeva O. Y., Torkhovskaya T. I., Baskaev K. K., Artyushev R. I., Saburina I. N., et al. High-density lipoproteins as homeostatic nanoparticles of blood plasma. Int J Mol Sci. 2020; 21 (22): 8737. doi: 10.3390/ijms21228737

23. Pizov A. V., Pizov N. A., Skachkova O. A., Pizovа N. V. Endothelial function in normal and pathological conditions. Meditsinskiy sovet. 2019; 6: 154-159. (In Russ.). doi: 10.21518/2079-701X-2019-6-154-159

24. Shabrov A. V., Apresyan A. G., Dobkes A. L., Ermolov S. U., Ermolova T. V., Manasyan S. G., et al. Current methods of endothelial dysfunction assessment and their possible use in the practical medicine. Rational Pharmacotherapy in Cardiology. 2016; 12 (6): 733-742. (In Russ.). doi: 10.20996/1819-6446-2016-12-6-733-742